story of the week
Health-Related Quality of Life Associated With Sacituzumab Govitecan Therapy in Patients With HR+/HER2− Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Health-related quality of life with sacituzumab govitecan in HR+/HER2- metastatic breast cancer in the phase III TROPiCS-02 trial
Oncologist 2024 May 15;[EPub Ahead of Print], HS Rugo, P Schmid, SM Tolaney, F Dalenc, F Marmé, L Shi, W Verret, A Shah, M Gharaibeh, A Bardia, J CortesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.